Are steroids contraindicated in cerebral palsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroids in Cerebral Palsy: Contraindications and Considerations

Steroids are not contraindicated in cerebral palsy as a condition itself, but their use requires careful consideration of specific circumstances, comorbidities, and treatment goals.

General Principles for Steroid Use in Cerebral Palsy

Cerebral palsy (CP) is not a direct contraindication to steroid therapy. However, several important considerations should guide their use:

When Steroids May Be Indicated in CP Patients:

  1. Acute Neurological Conditions:

    • Bell's palsy - Oral steroids are strongly recommended within 72 hours of symptom onset 1, 2
    • Autoimmune encephalitis - IV methylprednisolone is recommended as first-line therapy 1
    • Immune checkpoint inhibitor-related toxicity - High-dose steroids are indicated for neurological complications 1
  2. Inflammatory Conditions:

    • Joint inflammation/arthralgia - Steroids may be considered for moderate to severe pain 1
    • Myasthenia gravis - Steroids are indicated for management 1

Specific Contraindications and Cautions:

  1. Guillain-Barré Syndrome:

    • Steroids are specifically not recommended in idiopathic GBS 1
    • IVIG or plasmapheresis are preferred treatments
  2. Postnatal Use in Premature Infants:

    • Significant concern exists regarding postnatal steroid use in premature infants
    • Associated with increased risk of cerebral palsy and neurodevelopmental impairment 3
    • The number needed to harm (NNH) for developing cerebral palsy is 7 3
  3. Relative Contraindications:

    • Uncontrolled hypertension
    • Uncontrolled diabetes
    • Acute peptic ulcer
    • Severe behavioral symptoms that may worsen with steroid therapy 1

Decision Algorithm for Steroid Use in CP Patients

  1. Assess the primary indication:

    • Is the steroid being used to treat CP itself? (Generally not indicated)
    • Is it for a concurrent condition? (May be appropriate)
  2. Evaluate risk factors:

    • Age (pediatric vs adult)
    • Comorbidities (diabetes, hypertension, etc.)
    • Current medications and potential interactions
    • History of steroid response/side effects
  3. Consider alternative treatments:

    • For neurological conditions like GBS, consider IVIG or plasmapheresis instead 1
    • For joint pain, consider non-steroidal options first
  4. If steroids are indicated:

    • Use the lowest effective dose for the shortest duration
    • Monitor closely for adverse effects
    • Implement appropriate prophylaxis (e.g., eye protection in Bell's palsy) 1, 2

Special Considerations in Pediatric CP Patients

Children with CP require additional considerations:

  • Evidence for steroid use in pediatric Bell's palsy is less robust than in adults 1, 4
  • All children with Bell's palsy in one study recovered with or without steroid treatment 4
  • Postnatal steroid exposure in premature infants significantly increases CP risk 3
  • Benefit-harm assessment must be carefully weighed in each case

Conclusion

While cerebral palsy itself is not a contraindication to steroid therapy, the decision to use steroids in patients with CP should be based on the specific indication, potential benefits, and risks. For certain conditions like Bell's palsy and autoimmune encephalitis, steroids may be appropriate despite the presence of CP. However, for conditions like Guillain-Barré syndrome, steroids should be avoided. The most important consideration is to evaluate each case individually based on the specific neurological condition being treated and the patient's overall clinical picture.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Management of Sudden Onset Paralysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.